[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622028":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":42,"centralContacts":47,"locations":53,"responsibleParty":77,"collaborators":80,"id":83,"slug":51,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":88,"eligibilityCriteria":89,"healthyVolunteers":90,"sex":91,"minAge":92,"maxAge":93,"enrollmentInfo":94,"targetDuration":51,"studyType":97,"phases":98,"briefSummary":100,"conditions":101,"keywords":51,"overallStatus":104,"whyStopped":51,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"Shaheed Benazir Bhutto University Sheringal Dir Upper","OTHER",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Rosuvastatin (5mg, 20mg, 40mg)","EXPERIMENTAL","The assigned participants will be given Rosuvastatin 5mg, 20mg, 40mg OD for two days",[13],"Drug: Rosuvastatin (5mg, 20mg, 40mg)",{"label":15,"type":10,"description":16,"interventionNames":17},"Atorvastatin (10mg,20mg, 40mg)","The assigned participants will be given Atorvastatin 10mg,20mg, 40mg OD for two days",[18],"Drug: Atorvastatin (10mg, 20mg, 40mg)",{"label":20,"type":10,"description":21,"interventionNames":22},"Simvastatin (10mg, 20mg, 40mg)","The assigned participants will be given Simvastatin 10mg, 20mg, 40mg OD for two days",[23],"Drug: Simvastatin (10mg, 20mg, 40mg)",[25,31,36],{"type":26,"name":20,"description":27,"armGroupLabels":28,"otherNames":29},"DRUG","The Simvastatin (10mg, 20mg, 40mg) group participants will be given the drug orally OD for two days",[20],[30],"Simvastatin",{"type":26,"name":9,"description":32,"armGroupLabels":33,"otherNames":34},"The Rosuvastatin (5mg, 20mg, 40mg) group participants will be given the drug orally OD for two days",[9],[35],"Rosuvastatin",{"type":26,"name":37,"description":38,"armGroupLabels":39,"otherNames":40},"Atorvastatin (10mg, 20mg, 40mg)","The Atorvastatin (10mg, 20mg, 40mg) group participants will be given the drug orally OD for two days",[15],[41],"Atorvastatin",[43],{"name":44,"affiliation":45,"role":46},"Dr Abid Ullah, PhD","Shaheed Benazir Bhutto University,sheringal","PRINCIPAL_INVESTIGATOR",[48],{"name":44,"role":49,"phone":50,"phoneExt":51,"email":52},"CONTACT","+92 302 8533155",null,"abid@sbbu.edu.pk",[54,73],{"facility":5,"status":51,"city":55,"state":56,"zip":51,"country":57,"countryCode":58,"cosmosGeoPoint":59,"geoPoint":64,"contacts":65},"Dīr","Khyber Pakhtunkhwa","Pakistan","PK",{"type":60,"coordinates":61},"Point",[62,63],71.8768,35.2074,{"lat":63,"lon":62},[66,70],{"name":67,"role":49,"phone":68,"phoneExt":51,"email":69},"Dr Shujaat Ahmad, PhD","0944885400","shujat@sbbu.edu.pk",{"name":71,"role":72,"phone":51,"phoneExt":51,"email":51},"Prof Dr. Niaz Ali, PhD","SUB_INVESTIGATOR",{"facility":5,"status":51,"city":55,"state":56,"zip":51,"country":57,"countryCode":58,"cosmosGeoPoint":74,"geoPoint":76,"contacts":51},{"type":60,"coordinates":75},[62,63],{"lat":63,"lon":62},{"type":46,"investigatorFullName":78,"investigatorTitle":79,"investigatorAffiliation":5,"oldNameTitle":51,"oldOrganization":51},"Dr Abid Ullah","Lecturer",[81],{"name":82,"class":6},"Khyber Medical University Peshawar","100622028",false,"NCT07378293","Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers","Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers: A Randomized Phase I Clinical Trial","[Statins]","Inclusion Criteria:\n\n* healthy volunteers\n* Non diabetic\n* blood glucose level (less than140 mg\u002Fdl)\n\nExclusion Criteria:\n\n* Participants with a history of diabetes mellitus\n* With chronic diseases e.g heart disease, kidney disease\n* participants taking other medications",true,"ALL","18 Years","55 Years",{"count":95,"type":96},100,"ESTIMATED","INTERVENTIONAL",[99],"PHASE1","This Phase I randomized clinical trial aims to investigate the short-term effects of three commonly prescribed statins (atorvastatin, rosuvastatin, and simvastatin) at different dose levels on blood glucose homeostasis in healthy volunteers. The study will assess changes in fasting blood glucose, insulin, and C-peptide levels following two days of statin administration under controlled conditions. The research seeks to provide comparative data on the potential diabetogenic effects of these medications.",[102,103],"Diabete Mellitus","Lipid Profile","NOT_YET_RECRUITING","2026-01-26",{"date":107,"type":108},"2026-01-30","ACTUAL",{"date":110,"type":96},"2026-03-01",{"date":112,"type":96},"2027-02-20",{"name":5,"class":6},2]